PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

PROS ans CONS, page-2

  1. 1,203 Posts.
    lightbulb Created with Sketch. 225
    Some valid points & I agree the sci is good or I wouldn't be here.
    But I'm sorry I don't like Paul not even a little bit he has massively underachieved for shareholders IMO but still done very well for himself,
    Totally unacceptable he needs to go & as for any " performance bonuses" they need to be linked to the SP & nothing else
    I still think it's a great product but it needs someone with the commercial acumen to get a deal done. The current SP is ridiculous for a biotec so far down the line with great results. Management has to accept responsibility for that
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.010(3.92%)
Mkt cap ! $85.70M
Open High Low Value Volume
24.5¢ 25.0¢ 24.0¢ $59.66K 241.2K

Buyers (Bids)

No. Vol. Price($)
4 78837 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 36290 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.